Insulin degludec is an ultra-long-acting insulin analog developed for the study of hyperglycemia associated with type 1 and type 2 diabetes. Insulin degludec exhibits binding efficiency to the insulin receptor with an IC50 of 19.59 nM. Insulin degludec is applicable in diabetes research for evaluating pharmacological properties of basal insulin therapies.
Molecular Weight:
6103.97
CAS Number:
[844439-96-9]
Formula:
C274H411N65O81S6
Target:
IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted